Abstract
This study evaluated the potential of using poly(NiPAAm-co-AAc) as an injectable drug delivery carrier and a cell therapeutic agent in the form of a supporting matrix for the chondrogenic differentiation of rabbit chondrocytes. In particular, rabbit chondrocytes were embedded in hydrogels containing a combination of ascorbate and transforming growth factor β-3 (TGF β-3). Hydrogel constructs containing embedded cells either without ascorbate or a combination of ascorbate and TGF β-3 were used as controls to determine the effects of ascorbate and TGF β-3 on chondrogenic differentiation. The level of cartilage associated ECM proteins was examined using immunohistochemical staining for collagen type II as well as by Safranin-O and Alcian blue (GAG) staining. The results showed that ascorbate is an important factor for preparing cartilage constructs because of its action on chondrocyte phenotype modulation and proliferation.
| Original language | English |
|---|---|
| Pages (from-to) | 897-905 |
| Number of pages | 9 |
| Journal | Journal of Biomedical Materials Research - Part A |
| Volume | 83 |
| Issue number | 4 |
| DOIs | |
| State | Published - 15 Dec 2007 |
Keywords
- Ascorbate
- Cartilage
- Chondrocytes
- Injectable
- Transforming growth factorβ-3 (TGFβ-3)